These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2501848)

  • 1. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile].
    García-Quintana HG; Polette M; Ríos J
    Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
    Santini G; Targa S; Basaglia M; Marchetti G; Crovatto M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):242-6. PubMed ID: 6416270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic sensitivity and pyocin dependence of clinical strains of Ps. aeruginosa].
    Savitskaia KI; Levina EN
    Antibiotiki; 1977 Dec; 22(12):1117-21. PubMed ID: 413475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Petrocheilou-Malliara K; Koukoubanis N; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):199. PubMed ID: 3151341
    [No Abstract]   [Full Text] [Related]  

  • 6. Level of resistance of clinical isolates of Pseudomonas aeruginosa as related to their susceptibility to phages and R-pyocins.
    Legakis N; Koukoubanis N; Malliara K; Tumah H
    Chemioterapia; 1987 Jun; 6(2 Suppl):200-1. PubMed ID: 3151342
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro pyocin activity of Pseudomonas aeruginosa strains pretreated with antibiotics.
    Al-Ani FY; Al-Shibib AS
    Folia Microbiol (Praha); 1985; 30(4):349-52. PubMed ID: 3928466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pyocin typing of Pseudomonas aeruginosa strains].
    Moroz AF; Petropavlovskaia IS; Osokina TI; Frolova VV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):31-5. PubMed ID: 6422681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible use of pyocins against Pseudomonas aeruginosa (author's transl)].
    Sezen IY; Blobel H; Scharmann W
    Zentralbl Bakteriol Orig A; 1974; 229(2):205-8. PubMed ID: 4155865
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of Pseudomonas aeruginosa in relation to pyocine typing drug sensitivity and epidemiology.
    Mohanty SK; Bhuyan BK; Nathsarma KC; Nanda BK
    Indian J Pathol Microbiol; 1982 Jan; 25(1):45-9. PubMed ID: 6809612
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relations between antibiotic resistance and pyocin P3 resistance in Pseudomonas aeruginosa mutants].
    García-Quintana HG; Wilckens R
    Zentralbl Veterinarmed B; 1983 Apr; 30(3):169-74. PubMed ID: 6408850
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microbial resistance to various disinfectants. I. Phenol and aldehyde preparations].
    Janowska J; Krzywicka H
    Rocz Panstw Zakl Hig; 1980; 31(5):533-40. PubMed ID: 6781060
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening of effective agents for decreasing microorganism resistance to antibiotics].
    Klimniuk SI
    Antibiotiki; 1984 Mar; 29(3):182-4. PubMed ID: 6428303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
    Ohsumi M; Shinomiya T; Kageyama M
    J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibility of using purified pyocins for typing Pseudomonas aeruginosa: purification of pyocins and sensitivity of P. aeruginosa in different tests.
    Jurado Chacon D; Chueca Sancho A; Guillen Solvas JF; Garcia-Villanova Ruiz B; Galvez Vargas R
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(3):253-66. PubMed ID: 3122639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-expressed pyocins for control of Pseudomonas aeruginosa.
    Paškevičius Š; Starkevič U; Misiūnas A; Vitkauskienė A; Gleba Y; Ražanskienė A
    PLoS One; 2017; 12(10):e0185782. PubMed ID: 28973027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation on the antibacterial properties of some 5-pyrimidinecarboxylic acid derivatives.
    Cieplik J; Pluta J; Flendrich M
    Acta Pol Pharm; 1994; 51(1):59-62. PubMed ID: 7976436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance of bacteria to various disinfectants. II. Chloramine and iodophor preparations].
    Krzywicka H; Janowska J
    Rocz Panstw Zakl Hig; 1981; 32(4):371-7. PubMed ID: 6805067
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study of an aerosol preparation containing gentamicin (gentasol)].
    Rubtsova LK; Musiĭchenko AN; Eĭdel'shteĭn SI
    Antibiotiki; 1976 Feb; 21(2):166-9. PubMed ID: 818945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.